Curaleaf Holdings said on Wednesday it would buy Cura Partners Inc’s Select brand in an all-stock deal valued at $948 million to create the world’s largest cannabis company by revenue.
The deal is expected to expand the company’s presence on the US West coast, while adding Select-branded weed oil to its portfolio of vape oils, topical lotions, capsules, mints and lozenges.
The pot industry has seen a string of deals in recent months as companies look to boost the scale of their operations in the United States, with the recreational use of cannabis now legal in 10 states and the District of Columbia and medical marijuana legal in 23 states.
“This acquisition firmly establishes us not only as the largest US cannabis company by market cap but also as the largest cannabis company globally on a revenue basis,” Curaleaf Executive Chairman Boris Jordan said on a conference call.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Skadden Follows US Firms in Shutting Down Shanghai Operations
Oct 20, 2024 by
CPI
K&L Gates Strengthens Brussels Office with High-Profile Antitrust Hire from Gibson Dunn
Oct 20, 2024 by
CPI
Tobacco Giants Settle Historic $23.6 Billion Lawsuit in Canada
Oct 20, 2024 by
CPI
Meta Releases AI That Can Check and Improve Other AI Without Human Input
Oct 20, 2024 by
CPI
FTC Appeals Texas Ruling on Noncompete Agreement Ban
Oct 20, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh